Mild : Actualité Mild en direct - P1 | Bourse Reflex
Accueil > Tags > Mild

  • Toutes les actualités en rapport avec « Mild »

19/06 07:30 Mild - Quantum Genomics details positive results from its Phase IIa trial of QGC001 for the treatment of arterial hypertension

01/06 19:00 Mild - GENTICEL ANNOUNCES PUBLICATION IN 'CLINICAL CANCER RESEARCH' OF PHASE 1 TRIAL RESULTS SUPPORTING SAFETY, TOLERABILITY AND IMMUNOGENICITY OF GTL001

01/12 18:00 Mild - Fermentalg presents 5 new innovative products in a world premier at the Fi Europe 2015 trade fair devoted to the human nutrition market

26/01 20:15 Mild - Genticel to continue per protocol its Phase 2 clinical study with ProCervix after 2nd review by the DSMB

08/08 16:05 Mild - Apricus Biosciences to File for Market Authorization to Sell Vitaros(R) for Erectile Dysfunction in Latin America

05/08 09:00 Mild - Apricus Biosciences Provides Corporate Mid-Year Update

19/07 16:00 Mild - Apricus Biosciences Files Marketing Application for Vitaros(R) as a Treatment for Erectile Dysfunction in Switzerland

27/06 16:00 Mild - Apricus Biosciences Reports Reanalysis of Its U.S. Phase III Trials for MycoVa(TM) Showing Drug is Effective in Mycological Cure Resulting in Eradication of Nail Fungus

24/05 09:35 Mild - DreamWorks Animation's Kung Fu Panda 2 Kicks Its Way Into Select IMAX 3D(R) Theatres Starting This Wednesday

20/05 16:10 Mild - Apricus Biosciences Will Request Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Switzerland, Based on Guidance From Swiss Regulatory Authorities

28/04 16:10 Mild - Apricus Biosciences Requests Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Europe

28/04 11:05 Mild - Apricus Biosciences Requests Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Europe

01/03 15:15 Mild - Apricus Biosciences Announces Expanded European Patent Coverage for MycoVa(TM) for Nail Fungus

14/02 16:15 Mild - Apricus Biosciences and Neopharm Group Sign Licensing Agreement for Vitaros(R) in Israel for up to USD 4.35 Million, Plus Royalties

19/01 17:45 Mild - Apricus Biosciences Reports Additional Analysis Showing That MycoVa(TM) is as Effective for the Treatment of Nail Fungus as the Current European Standard of Care for Topical Therapy, Loceryl(R)

23/12 09:00 Mild - Apricus Biosciences and Bracco Sign Licensing Agreement for Vitaros(R) in Italy

08/02 11:20 Mild - TMO Renewables Limited : La société TMO a été sélectionnée pour participer à la Conférence CleanEquity Monaco 2010 4- 5 mars 2010

24/10 13:32 Mild - RECORDATI OBTIENT UNE AUTORISATION DE MISE SUR LE MARCHÉ EUROPÉENNE POUR PITAVASTATIN

13/02 12:13 Mild - HAUSSE DES RESULTATS INDUSTRIELS ET DU DIVIDENDE